Moffitt Cancer Center

02/09/2026

One week before starting his new job at Moffitt Cancer Center, psychologist Jordie Poncy, PhD, went to the ER for a lingering stomach ache—and left with a diagnosis of neuroendocrine carcinoma.

Overnight, he became a cancer patient at the very place where he was preparing to help others heal.

He began treatment and eventually started his professional role at Moffitt five months later, but as someone living both sides of cancer care.

Between treatment appointments and chemo infusions, he started to find balance, purpose and perspective.

After his diagnosis, Jordie turned to creativity to help process his experience. A piece he created shortly after his diagnosis portrays three roles: a person, a patient and a provider.

Today, Jordie brings more than clinical expertise to his work. He brings deeper empathy, understanding and connection to his patients.

As he continues treatment, he says cancer has changed him but hasn’t taken away from who he is.

Read more of his story: https://bit.ly/4t4RVMb

02/08/2026

Did you know 1 in 8 men will be diagnosed with prostate cancer in their lifetime? Gronk and Bruce Arians team up in an ad urging men to take charge of their prostate health with a simple PSA blood test.

Gronk and former Bucs coach Bruce Arians team up in an ad urging men to get PSA test

02/08/2026

As a teacher, coach and professional snow skier, Bob McIntee spent his life helping others discover their strength.

When Bob was diagnosed with late-stage pancreatic cancer in 2023, he was told he had three to six months. But his family wasn't ready to accept that.

Within six days, Bob had an appointment at Moffitt Cancer Center.

After chemotherapy and radiation had run their course, he was offered one more option: a clinical trial targeting a mutation in the KRAS gene — specifically KRAS G12D, the most common mutation found in pancreatic cancer and the one in Bob’s tumor.

As the first person enrolled in the trial, Bob saw his tumor shrink by 30% and experienced few side effects, allowing him to maintain his energy and stay active.

For the McIntees, the clinical trial provided an open door when they thought they were all shut.

And for others facing similar challenges, it’s a powerful reminder that being part of a trial can help write the next chapter in cancer care.

Please note: This story was originally written before the passing of Bob McIntee on Sept. 30, 2025. We share it in recognition of his life, his work and the lasting impact he made. We extend our sincere condolences to his family and all who loved Bob. 💙

02/07/2026

With colon cancer on the rise among young adults, a new study is listening to young survivors’ perspectives on diagnosis and care.

The findings will help shape a future digital health education program for young adults who aren’t yet eligible for screening—support patients like Mason say is needed.

Colorectal cancer rates are continuing to rise in young adults

02/07/2026

The latest episode of The ImmunoVerse dives into the breakthroughs behind cancer immunotherapy.

Learn how immune checkpoint inhibitors like anti–PD-1 work and what’s ahead, from combination therapies to AI-driven discovery.

🎧 Listen now at https://bit.ly/4rSsfkL or on your favorite podcast platform!

Featuring a conversation with Patrick Hwu, MD, and Drew Pardoll, MD, PhD.

02/06/2026

Will it be Seattle or New England taking home the trophy? 🏆

Our therapy dog, Daisy, took predictions into her own paws and kicked one team out to make her pick. 🏈

Drop a 🐾 if you agree with Daisy’s pick.

Fun fact: Daisy is a 4-year-old Australian labradoodle who has been volunteering at Moffitt with her owner, Cindy, for nearly a year.

02/05/2026

On World Cancer Day, Moffitt's Maurício Ribeiro, MD, joined ABC to share the meaning of ringing the bell after treatment and ways to help lower cancer risk.

02/05/2026

Join us in congratulating our President and CEO, Patrick Hwu, MD, on being named a Tampa Bay Business Journal 2026 Power 100 influential business leader.

This recognition reflects his commitment to advancing Moffitt Cancer Center as Florida’s premier cancer center and his leadership in the Tampa Bay community.

We are also proud to celebrate the leadership and impact of Moffitt's current and former board members on the Power 100 list.

Congratulations!
• Carlos Alfonso
• Frank Capitano
• Allison Casper Adams - Oxford Commons
• Paul Anderson - Port Tampa Bay
• Bryan Glazer
• Ken Jones
• Marty Lanahan - First Horizon Bank
• Rhea Law (Power 100 Legend) - University of South Florida
• Stu Sternberg (Power 100 Legend) - Tampa Bay Rays
• Ron Christaldi
• Moez Limayem - University of South Florida

Thank you for your commitment to advancing cancer care and innovation in the Tampa Bay community!

02/04/2026

This World Cancer Day focuses on personalized medicine and how each patient is unique.

Tailored therapies for individual patients are changing the way cancer is treated.

Personalized medicine plays a major role in cancer care because while the disease may look the same under a microscope, it can act differently in each patient.

This approach uses genetic sequencing to identify cancer mutations, administering targeted therapies and immunotherapies and adjusting treatment based on disease response.

Moffitt Cancer Center is a leader in personalized medicine, translating scientific discovery into individualized therapies that improve outcomes for patients.

02/03/2026

Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome configuration, they said their findings show tumors follow measurable rules.

02/03/2026

Did you know that excess weight is linked to at least 13 types of cancer? Experts are uncovering why and how to lower your risk.

Excess weight is linked to at least 13 cancers. Experts at Moffitt are uncovering why and how to lower the risk.

02/02/2026

Shadow spotted on Groundhog Day. Cooler temperatures may stick around, but UV rays are still strong. ☀️ Don’t forget sunscreen to help protect your skin and reduce skin cancer risk.